Statistical analysis of readthrough levels for nonsense mutations in mammalian cells reveals a major determinant of response to gentamicin.
about
Peroxisomal lactate dehydrogenase is generated by translational readthrough in mammalsTranslational readthrough potential of natural termination codons in eucaryotes--The impact of RNA sequenceTherapeutic suppression of premature termination codons: mechanisms and clinical considerations (review)Evaluation of Aminoglycoside and Non-Aminoglycoside Compounds for Stop-Codon Readthrough Therapy in Four Lysosomal Storage DiseasesNovel small molecules potentiate premature termination codon readthrough by aminoglycosidesAminoglycosides restore full-length type VII collagen by overcoming premature termination codons: therapeutic implications for dystrophic epidermolysis bullosa.Aminoglycoside-stimulated readthrough of premature termination codons in selected genes involved in primary ciliary dyskinesia.Aminoglycosides, but not PTC124 (Ataluren), rescue nonsense mutations in the leptin receptor and in luciferase reporter genes.Molecular analysis, pathogenic mechanisms, and readthrough therapy on a large cohort of Kabuki syndrome patients.Re-exploration of the Codon Context Effect on Amber Codon-Guided Incorporation of Noncanonical Amino Acids in Escherichia coli by the Blue-White Screening Assay.Effect of Readthrough Treatment in Fibroblasts of Patients Affected by Lysosomal Diseases Caused by Premature Termination CodonsA novel Werner Syndrome mutation: pharmacological treatment by read-through of nonsense mutations and epigenetic therapiesAtaluren as an agent for therapeutic nonsense suppression.Cryptic MHC class I-binding peptides are revealed by aminoglycoside-induced stop codon read-through into the 3' UTR.Gentamicin B1 is a minor gentamicin component with major nonsense mutation suppression activityTargeting Nonsense Mutations in Diseases with Translational Read-Through-Inducing Drugs (TRIDs).A flow cytometry-based reporter assay identifies macrolide antibiotics as nonsense mutation read-through agents.Small molecules as therapeutic agents for inborn errors of metabolism.When Proteins Start to Make Sense: Fine-tuning Aminoglycosides for PTC Suppression Therapy.Optimized approach for the identification of highly efficient correctors of nonsense mutations in human diseases.Exploiting non-canonical translation to identify new targets for T cell-based cancer immunotherapy.Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells.Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons.Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons.
P2860
Q21128767-3993724C-94A0-4796-9985-6FBA9F3CDC98Q26801496-E91A2820-B4C3-4061-88B9-E63557E02225Q26853614-4ED94A85-0F41-4650-A61E-D7F359788811Q28547356-A3EDF6A2-5B05-40E4-BCAA-2050982FEDE0Q28828711-DDF7CCB2-646C-47B2-8502-94A2A9DFFE9CQ30650123-11F84D3A-0371-49D7-A37E-776B9972188CQ30820082-B4F9E85E-33AA-498E-92E6-D05C5C842B08Q33681878-E481DDBA-B6B6-4363-A079-64FAE147B858Q34522233-7BBA1B85-64B3-4CF6-BC11-5BFE64E51214Q35973976-EA65E8B5-35FD-4D4F-996A-3E207FA7D27BQ36157628-5C76F70A-17C1-4248-9431-703A91E254FBQ36214442-22EDB0E3-D2DF-4C36-9D56-448AE0A79DA6Q37670599-8B1128BC-EAF2-4B98-8742-0207F4D773E5Q37712005-C673BB0A-7292-4DCA-85A4-D7CC5BD86251Q37737097-564AC0D0-F94B-439E-A38B-459854B5FF54Q38737126-1FC21162-E242-4839-9541-0ED791A61CADQ38815661-80BCC36A-9FE7-4941-A911-5AFCDD50A8AAQ39038060-3AE93662-A675-4096-8379-E371E378154FQ42142778-7F6390E0-43EF-4652-AA20-2FAAED7B2D8EQ45423056-75549A60-C348-4C61-B60A-21FEEE7DA936Q47797670-41F12307-D898-48B2-8418-2709C1A938C2Q51158606-3DFE5F9B-8F6B-4FEC-A273-4ECBA91DBBF0Q52677951-70E7E314-1895-4FBC-A0BE-426B9638BF1DQ55497000-A59D779A-1124-4C14-BC6E-2CE2080430CE
P2860
Statistical analysis of readthrough levels for nonsense mutations in mammalian cells reveals a major determinant of response to gentamicin.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Statistical analysis of readth ...... ant of response to gentamicin.
@ast
Statistical analysis of readth ...... ant of response to gentamicin.
@en
Statistical analysis of readth ...... ant of response to gentamicin.
@nl
type
label
Statistical analysis of readth ...... ant of response to gentamicin.
@ast
Statistical analysis of readth ...... ant of response to gentamicin.
@en
Statistical analysis of readth ...... ant of response to gentamicin.
@nl
prefLabel
Statistical analysis of readth ...... ant of response to gentamicin.
@ast
Statistical analysis of readth ...... ant of response to gentamicin.
@en
Statistical analysis of readth ...... ant of response to gentamicin.
@nl
P2860
P1433
P1476
Statistical analysis of readth ...... nant of response to gentamicin
@en
P2093
Célia Floquet
Jean-Pierre Rousset
P2860
P304
P356
10.1371/JOURNAL.PGEN.1002608
P577
2012-03-29T00:00:00Z